ArticleStem cell research & therapy2022

Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention.

Yan-Ruide Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.